back
Eurocare 3 Survival Trend 1983-1994
Cancer Site Population Age Class
Acute lymphatic leukaemiaMelanoma of skin
Acute myeloid leukaemiaMultiple myeloma
ALL CANCERSNasal cavities
BladderNasopharynx
BoneNon-Hodgkin's lymphomas
BrainOesophagus
BreastOral cavity
Cervix uteriOropharynx
Choroid (melanoma)Ovary
Chronic lymphatic leukaemiaPancreas
Chronic myeloid leukaemiaPenis
ColonPleura
Corpus uteriProstate
Biliary tractRectum
Head & NeckSalivary glands
Hodgkin's diseaseSmall intestine
HypopharynxSoft tissues
KidneyStomach
LarynxTestis
LeukaemiaThyroid gland
LipTongue
Liver, PrimaryVagina and vulva
LungColon & Rectum
DenmarkSaarlandNavarra
EindhovenIcelandTarragona
Dutch RegistriesTuscanySpanish Registries
East AngliaLatinaSweden
MerseyParmaBasel
OxfordRagusaGeneva
West MidlandsTurinSwiss Registries
YorkshireVareseSouthWest
English RegistriesItalian RegistriesThames
EstoniaCracowTrent
FinlandPolish RegistriesWales
CalvadosScotlandBas Rhin
Côte d'OrSlovakiaNorway
French RegistriesSloveniaEurope
Sex Period of Diagnosis
Male1983-1985
Female1986-1988
Male and Female1989-1991
1992-1994
15-44
45-54
55-64
65-74
75-99
All ages 15-99
Eurocare-3 standard
ICSS standard
20-44
20-99
15-54
75-84
85-99
Time from diagnosis
1year   8years
2years  9years
3years  10years
4years  11years
5years  12years
6years  13years
7years
Output Indicators
Number of cases Observed Survival, Interval (OSI) Relative Survival, Interval (RSI) Relative SE's, Interval (RSEI)
Alive at Start Observed Survival, Cum (OSC) Relative Survival, Cum (RSC) Relative SE's, Cum (RSEC)
Dead Expected Survival, Interval (ESI) Observed SE's, Interval (OSEI) RSC: Lower bound
Lost to Follow Up Expected Survival, Cum (ESC) Observed SE's, Cum (OSEC) RSC: Upper bound

Valid XHTML 1.0 Strict